GeneDx Holdings WGS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $94.92M-10.4% | $105.99M+9.3% | $96.96M+29.1% | $75.11M-25.4% | $100.69M+16.8% | ||
| $76.76M+15.8% | $66.29M+12.1% | $59.11M-2.2% | $60.44M+1.7% | $59.46M+6.2% | ||
| $260.27M+13.5% | $229.32M+19.1% | $192.58M+33.6% | $144.11M+53.8% | $93.68M+115% | ||
| $48.69M-0.9% | $49.11M+7.2% | $45.81M-0.4% | $46.01M+3.6% | $44.4M+2.4% | ||
| $270.63M+0.9% | $268.29M+12.9% | $237.58M+16.0% | $204.84M-9.3% | $225.82M+14.1% | ||
| $50.13M+9.7% | $45.69M+7.7% | $42.42M+5.7% | $40.12M+10.3% | $36.38M+10.6% | ||
| $1.64M— | —— | —— | —— | —— | ||
| $144.97M-14.0% | $168.48M-2.4% | $172.59M-2.3% | $176.69M+13.9% | $155.09M-2.2% | ||
| $506.3M-3.3% | $523.71M+6.0% | $493.9M+6.5% | $463.86M+3.9% | $446.43M+6.4% | ||
| $11.17M+354% | $2.46M-6.4% | $2.63M-25.3% | $3.52M-77.8% | $15.86M+99.3% | ||
| $0-100% | $4.54M+270% | $1.23M+0.5% | $1.22M+0.5% | $1.22M+0.5% | ||
| $87.64M-19.5% | $108.91M+24.3% | $87.62M+22.7% | $71.41M+2.7% | $69.54M+26.9% | ||
| $96.73M+101% | $48.18M-6.6% | $51.58M-0.2% | $51.68M-0.2% | $51.79M-0.2% | ||
| $220K-91.8% | $2.67M-98.7% | $201.64M+8.0% | $186.73M-1.2% | $189.03M+8.6% | ||
| 1B0.0% | 1B0.0% | 1B0.0% | 1B0.0% | 1B+49,999,900% | ||
| -$1.44B-4.6% | -$1.37B-1.3% | -$1.36B-0.6% | -$1.35B+0.8% | -$1.36B-0.5% | ||
| $254.12M-17.5% | $308.18M+5.4% | $292.26M+5.5% | $277.13M+7.7% | $257.41M+5.0% | ||
| $506.3M-3.3% | $523.71M+6.0% | $493.9M+6.5% | $463.86M+3.9% | $446.43M+6.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can GeneDx Holdings cover its short-term obligations?
- Its current ratio is 3.09 — current assets exceed current liabilities.
- Where does GeneDx Holdings's balance sheet data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.